References
- Berzenji L, Van Schil PE, Carp L. The eighth TNM classification for malignant pleural mesothelioma. Transl Lung Cancer Res. 2018;7(5). doi:10.21037/tlcr.2018.07.05
- Woolhouse I, Bishop L, Darlison L, et al. BTS guideline for the investigation and management of malignant pleural mesothelioma. BMJ Open Respir Res. 2018;5(1). doi:10.1136/bmjresp-2017-000266
- Popat S, Baas P, Faivre-Finn C, et al. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2022;33(2). doi:10.1016/j.annonc.2021.11.005
- Scherpereel A, Scherpereel A, Opitz I, et al. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. European Respiratory Journal. 2020;55(6). doi:10.1183/13993003.00953-2019
- Barbieri PG, Somigliana A, Girelli R, Lombardi S, Sarnico M, Silvestri S. [Pleural mesothelioma in a school teacher: asbestos exposure due to DAS paste]. Med Lav. 2016;107(2).
- Messina G, Bove M, Natale G, et al. Diagnosis of malignant pleural disease: Ultrasound as “a detective probe.” Thorac Cancer. 2023;14(3). doi:10.1111/1759-7714.14735
- Sinha S, Swift AJ, Kamil MA, et al. The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines. Clin Radiol. 2020;75(6). doi:10.1016/j.crad.2019.12.001
- Shiroshita A, Kurosaki M, Takeshita M, Kataoka Y. Medical thoracoscopy, computed tomography-guided biopsy, and ultrasound-guided biopsy for malignant pleural mesothelioma: A systematic review. Anticancer Res. 2021;41(5). doi:10.21873/ANTICANRES.14998
- Friedberg JS, Culligan MJ, Tsao AS, et al. A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute–International Association for the Study of Lung Cancer–Mesothelioma Applied Research Foundation Taskforce. Journal of Thoracic Oncology. 2019;14(8). doi:10.1016/j.jtho.2019.04.029
- Michael CW, Bedrossian CCWM, Sadri N, Klebe S. The cytological features of effusions with mesothelioma in situ: A report of 9 cases. Diagn Cytopathol. Published online 2023. doi:10.1002/dc.25129
- Courtiol P, Maussion C, Moarii M, et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome. Nat Med. 2019;25(10). doi:10.1038/s41591-019- 0583-3
- Borgeaud M, Kim F, Friedlaender A, Lococo F, Addeo A, Minervini F. The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma. J Clin Med. 2023;12(5). doi:10.3390/jcm12051757